European Archives - Page 638 of 1178 - European Medical Journal

Talking to Rodrigo Garcia

Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.

What Factors Affect Timing of Menopause?

Combining multiple health surveys in a meta-analysis, Duke Appiah, Texas Tech University, Lubbock, Texas, USA, has produced interesting insights for the duration of a woman’s reproductive span. Lifestyle factors were analysed to show associations with the date women reach natural menopause.

Women with PCOS at High Risk for COVID-19

Domminating the statistics for infertility in women, polycystic ovary syndrome (PCOS) is the most common cause of this condition, with onset as a result of imbalanced reproductive hormones. Emerging evidence suggests a co-interaction of PCOS with infectious disease.

EMJ Podcast: COVID to Ground Control

This week, Jonathan muses on the importance of emerging from the pandemic safely, addressing conspiracy theories, vaccine hesitancy, public uncertainty, and the role of strong leadership, all through an analogy of aviation.

Prostate specific antigen PSA blood culture sample with catheter and collection tubes.

Webinar: Beyond PSA: Utility of a Urine Gene Expression Assay for Early Detection of Prostate Cancer

PSA remains the gold standard as a first-line screening test, but is limited in terms of specificity, especially among older men. We now have available new, non-invasive biomarkers which can help men decide whether to proceed with biopsy, in order to find high-grade, potentially lethal tumors early while minimizing over-diagnosis of low-grade, indolent tumors.

The expectation vs reality of drug launch

This infographic reviews drug launches from recent years, comparing the expectation vs reality of launch, the increase in first-time launchers, and the impact of COVID-19 on the landscape.

Editor's Pick: Relating Ventilatory Support and Drug Treatment Strategies to the Fundamental Pathophysiology in COVID-19 Illness

Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);1 as of September 2020, there were >33 million…

Autosomal Dominant Polycystic Kidney Disease in Children

In this webinar focusing on Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Children, Djalila Mekhali, University Hospital of Leuven, Belgium, presents a comprehensive account of the disease and its progression.

A Way to Diagnose Protein Energy Wasting in Children with Kidney Disease

CHILDREN with kidney disease are vulnerable to protein energy wasting (PEW), reported an observational study from St John’s National Academy of Health Sciences, Bangalore, India.

Hospitalised Patients with COVID-19 and Kidney Disease

PATIENTS hospitalised due to COVID-19 with end-stage renal disease (ESRD) showed better outcomes than patients with non-dialysis chronic kidney disease (CKD), an observational, retrospective study from New York City, New York, USA, reported.